Fibrinolysis Shutdown in COVID-19-Associated Coagulopathy: A Crosstalk among Immunity, Coagulation, and Specialists in Medicine and Surgery

TY - JOUR

T1 - Fibrinolysis Shutdown in COVID-19-Associated Coagulopathy

T2 - A Crosstalk among Immunity, Coagulation, and Specialists in Medicine and Surgery

AU - Walsh, Mark M.

AU - Khan, Rashid

AU - Kwaan, Hau C.

AU - Neal, Matthew D.

N1 - Funding Information: Support: Dr Neal receives research support from NIH and the US Department of Defense . Funding Information: Disclosures outside the scope of this work: Dr Walsh receives lecture payments from Alexion Speakers Bureau. Dr Neal receives payment for board membership from Janssen Pharmaceuticals and CSL Behring, and receives research support from Janssen Pharmaceuticals, Haemonetics, Accriva, Diagnostics, Instrument Laboratories, and Noveome Therapeutics. Other authors have nothing to disclose.Support: Dr Neal receives research support from NIH and the US Department of Defense.

PY - 2021/6

Y1 - 2021/6

UR - http://www.scopus.com/inward/record.url?scp=85103960308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85103960308&partnerID=8YFLogxK

U2 - 10.1016/j.jamcollsurg.2021.03.003

DO - 10.1016/j.jamcollsurg.2021.03.003

M3 - Comment/debate

C2 - 33839011

AN - SCOPUS:85103960308

SN - 1072-7515

VL - 232

SP - 1003

EP - 1006

JO - Journal of the American College of Surgeons

JF - Journal of the American College of Surgeons

IS - 6

ER -